Ko e Cartalax ko ha peptide fakatupu seini nounou mo e hokohoko 'o e 'esiti 'amino 'Ala-Glu-Asp .. Ma'u mei ha konga polotini fakanatula 'oku 'i loto 'i he cartilage mo'ui lelei ., ko ha molekula fakatupu ia na‘e fa‘u fakalelei ..
Ko e hokohoko pau ‘o e ngaahi ‘ēsiti ‘amino ‘okú ne fa‘ifa‘itaki ki he ngaahi ‘ēsiti ‘o e . fakalotofonua ngaahi molekula faka'ilonga; ha'i ki he ngaahi receptors selula pau ., 'oku fakatupu 'e ha cascade kimui ange 'o e ngaahi tali 'a e selo ..
'Oku foaki 'e he tisaini synthetic fakakaukau 'a e Cartalax 'ekitiviti fakapaiolosia ma'olunga ., fakaikiiki, ma'ulalo 'a e malu'i, mo e lelei 'o e transdermal pe ngutu ..
Fakaikiiki 'a e fakatotolo hokohoko 'a 'ene ngaahi taumu'a lahi ., lahi-levolo fakalukufua 'o e malu'i mo e reparative 'a e malava.
Ko hono ta‘ofi ola lelei ‘o e pupulá ko e taha ia ‘o e ngaahi ola peheé . – fakatonutonu hifo 'o e saitokaini fakatupu vela fakatupu Ngaahi polotini ukamea (Ngaahi MMP) mo e 'ĀTAMI ko e ngaahi founga tefito .; fakahangatonu 'a e 'auha mo e faka'auha 'o e fa'ahinga II collagen mo e ngaahi kehekehe . polotiokalaikani are mitigated, articular cartilage structural integrity being preserved.
Enhancing the regenerative capacity of the matrix 'i tu'a 'i he selo is another line of action suggested by more recent studies; chondrocyte specific markers are upregulated and their synthesis promoted.
Minor cartilage damage can be repaired through these means, healthy homeostasis tauhi.
Fakafepaki'i 'o e pupula, immunomodulatory and anti-aging properties are all part of Cartalax’s profile; clinical trials are currently exploring all of the above.
Synthesis and application of Cartalax represents a promising direction of bioactive peptide therapy.
Fakahokohoko
Ala-Glu-Asp
Fika CAS
/
Fomula Molekula
C12H19N3O8
Mamafa Molekula
333.297
Research Of Cartalax Peptide
1.Inhibition of Cartilage Catabolism
As stated, the prevention of excessive degradation is at the core of all Cartalax based research.
Abnormal pro-inflammatory factor signaling must be interrupted, mo e ngaahi enzymes 'oku nau fatongia'aki hono faka'auha 'o e matrix . (toe 'ai, tefito MMPs/Matilikisi Metalipolotini) pe 'oku ta'ofi fakahangatonu pe ta'efakahangatonu ..
Ko e angatonu fakamisini 'o e tisiuu 'o e cartilage ko e ngata'anga ia 'o e ngaue kotoa pe ko 'eni ..
2.Faka'ai'ai Ko e hui Fakatahataha'i
'Oku fakahaa'i foki 'e he Cartalax ha malava makehe ke fakalahi 'a e metabolism 'o e tisiuu anabolic ..
Fakatonutonu chondrocyte ngaue fakangaue, 'oku ne fakalahi vave 'a e synthesis mo e secretion kimui ange 'o e ngaahi konga kehekehe 'o e matrix 'o e extracellular .; Ko e fa'u fakahangatonu 'o e cartilage ko e ola faka'osi tefito ia 'o e founga ko 'eni ..
Kuo fakapapau'i 'e he ngaahi ako 'i he vitro 'a e ola ko 'eni . – faito'o chondrocytes pe 'oku fakahaa'i 'e he ngaahi selo 'o e 'akau 'a e ngaahi tu'unga 'o e fakahaa'i 'o e gene 'o e fa'ahinga II collagen mo e . ʻakelikani, mo e ngaahi fakalahi fe'unga 'i hono ngaohi mo'oni 'o e ngaahi polotini ko ia ..
Further indirect enhancement of cellular metabolism and protein synthesis are achieved through specific intracellular signaling pathways (TGF-β/Smad being a prime example); tissue regeneration is the desired outcome.
Repairing pre-existing microdamage and constructing a functional matrix are two valuable pathways enabled by this line of action.
3.Anti-inflammatory and Immunomodulatory Effects
NF-κB serves as a key signal for activating numerous inflammatory factors.
Cartalax actively suppresses, or at least reduces, NF-κB expression – hitting the source of most inflammatory responses.
Pain, swelling and the more permanent stiffness associated with inflammation are all effectively alleviated.
The cartilage protective effects described above are intrinsically part of this anti-inflammatory process; ko hono fakasi’isi’i ‘o e vela ko ha tafa’aki tefito ia ‘o e founga fakalukufua ‘o e ngaue ‘a e Cartalax ..
COA
HPLC
MS





